Review of Patent Technology for Anti-HBV Pyrazolopiperidines to Nucleocapsid Targets
This article summarizes and analyzes the patent technology evolution of pyrazolopiperidine compounds through searching,statistics,and analysis of global patent application literature for the treatment of HBV nucleocapsid inhibitors.It also studies the relevant technical layout of important applicants such as Novira,Aicuris,and Janssen,revealing the current status and future development trends of nucleocapsid inhibitors for the treatment of HBV.
万方数据
维普
